PT - JOURNAL ARTICLE AU - Paul Naaber AU - Kaidi Hunt AU - Jaana Pesukova AU - Liis Haljasmägi AU - Pauliina Rumm AU - Pärt Peterson AU - Jelena Hololejenko AU - Irina Eero AU - Piia Jõgi AU - Karolin Toompere AU - Epp Sepp TI - Evaluation of SARS-CoV-2 IgG antibody response in PCR positive patients: comparison of nine tests in relation with clinical data AID - 10.1101/2020.07.15.20149617 DP - 2020 Jan 01 TA - medRxiv PG - 2020.07.15.20149617 4099 - http://medrxiv.org/content/early/2020/07/17/2020.07.15.20149617.short 4100 - http://medrxiv.org/content/early/2020/07/17/2020.07.15.20149617.full AB - Background High number of SARS-CoV-2 antibody tests are available in different formats, detect different types of antibodies, and use different target proteins. Sensitivity of these tests varies and could be also related to clinical symptoms and testing time.Methods Serum samples from 97 COVID-19 patients and 100 controls were tested with 9 antibody tests (SNIBE, Epitope, Euroimmun, Roche, Abbott, DiaSorin, Biosensor, LIPS N, and LIPS S-RBD). The results were analyzed in context of clinical data.Findings Positivity rate was of tests was following: N-LIPS test (91.8% cases), Epitope (85.6%), Abbott and in-house LIPS S-RBD (both 84.5%), Roche (83.5%), Euroimmun (82.5%), DiaSorin (81.4%), SNIBE (70.1%), and Biosensor (64.9%). Agreement between tests varied (71-95%). Correlation between patient symptoms score and antibody value was test-dependent: varied from strongest in LIPS N (ρ=0.41; p<0.001) to nonsignificant (LIPS S-RBD). Testing time from symptoms influenced sensitivity in some tests more than another’s.Interpretation Sensitivity of tests varied highly and combination of different tests may improve it. Relation of results to symptoms and testing time was test-dependent. Thus, some antibody tests seems to be more sensitive to detect antibodies early and in asymptomatic patients than others.Funding Study was funded by SYNLAB Estonia and Estonian Research Council grant PRG377.Evidence before this study High variation in COVID-19 antibody tests sensitivity has been described. Relation between antibody response and clinical cause has been found in some studies but not in others. It’s known that antibody response is time dependent, however seroconversion medians varied in different studies.Added value of this study We confirmed that SARS-CoV-2 antibody response depends on clinical symptoms and time of testing, but we also found that this relation is dependent on test setup and viral antigens used in the tests. This may explain contradictory results of previous studies.Implications of all the available evidence Our study has practical implications showing that not all antibody tests work uniformly well in symptomatic and asymptomatic cases and in different time periods from disease onset. This should be taken into consideration in clinical practice for diagnosing COVID-19 and in epidemiological studies evaluating the seroprevalence especially in asymptomatic population.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThe study was supported by SYNLAB Estonia and Estonian Research Council grant PRG377Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Study has been approved by Ethical Committee of Tartu University on April 23, 2020 (nr 311/T-1).All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesAll data is available by request